Harvard Bioscience (HBIO) executive compensation, 2026 proxy

John Duke, President & Chief Executive Officer, was paid $905,208 in 2025.

Filed
April 21, 2026
Annual meeting
June 2, 2026
Pay year
2025
Named executives
4
CEO total pay
$905,2082025
CEO pay in equity
66%$598,900 in awards
CEO Base Salary
$515,000Under amended agreement
CFO Base Salary
$375,000Under amended agreement
Refinancing Bonus
$100,000Paid to CEO and CFO

How Duke was paid

$905,208 in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary22%Bonus11%Stock awards66%All other compensation0%

Named executive officers

ExecutiveTotal
John DukePresident & Chief Executive Officer$905,208
Mark FrostChief Financial Officer & Treasurer$343,518
James W. GreenFormer Chairman, President & Chief Executive Officer$355,823
Jennifer CoteFormer Chief Financial Officer and Treasurer$123,006

What changed and why

  • $905KJohn Duke received a total compensation of $905,208 for fiscal year 2025 following his appointment as CEO in July 2025.
  • $344KMark Frost earned a total compensation of $343,518 for fiscal year 2025 after stepping in as CFO.
  • $100KBoth executives received a $100,000 cash bonus based on the successful refinancing of the company credit facility.
  • $356KJames W. Green served as CEO until August 2025, receiving total compensation of $355,823.
  • $123KJennifer Cote served as CFO until May 2025, receiving total compensation of $123,006.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.